Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "feed" return 12 results.
Ceva’s 2018 Hatchery of the Year award is proudly awarded to Quantum Foods Limited, Zambia >
This is the 4th year that Ceva is running their Hatchery of the Year challenge. This year, Quantum Foods Zambia is the proud winner, with Ross Poultry Breeder, Zambia in second place and Supreme Poult...
Reproduction >
Intra-vaginal device for use in well-fed and managed dairy and beef Heifers and cows to initiate or synchronize oestrus.
Ceva presents a complete range of vector vaccines at IPE 2013 >
25 January 2013 Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Ceva, a socially responsible company committed to the well-being of the planet
Our Core Values >
CEVA South Africa is committed to the following core values:
Our Mission >
Ceva believes that a new approach to world health is required which goes beyond animal health
Frequently asked questions - Vectormune® >
Vectormune ® FP-MG What is the interest level for the newest Vectormune ® FP-MG vaccine? Questions and Answers about MG What is the average percent of incidence of MG in the layer complexes acro...
Metabolism >
Rehydion® Gel is an electrolyte solution as supportive treatment to address the effects caused by diarrhoea in calves. Multivit - is a Vitamin supplement in an effervescent tablet, to be dissolved in...
Pharmaceuticals and others >
Anti-infectives and other speciality pharmaceuticals
Vectormune FP-MG >
What is the interest level for the newest Vectormune FP-MG vaccine?